Benjamin Rowlatt

Ben’s practice focuses on complex IP disputes, through which matters he has cultivated an extensive background with both UK and wider multijurisdictional European litigation.

With his first degree in chemistry, Ben handles all manner of chemical, pharmaceutical, and biotech patent litigation, with a diverse practice spanning small molecule drugs, antibody therapies, drug manufacturing, therapeutic applications, DNA sequencing, biopesticides, and more. Ben’s life sciences matters also often see him working at the interface of IP law and pharmaceutical regulatory issues, such as research exemptions and Supplementary Protection Certificates.

Ben also advises on patent cases dealing with all manner of technologies, including telecommunications, computer networking, as well as mechanical and electrical engineering.

In addition to litigation before the UK courts, a significant proportion of Ben’s practice involves multijurisdictional disputes. Ben’s matters have seen him at the forefront of coordinating local counsel teams in parallel litigation across Europe, as well as attending hearings in an array of European national courts and at the European Patent Office. The establishment of the Unified Patent Court in Europe has also seen Ben expand his coordination experience to include this extra dimension.

• Represented a biotech company in a patent action regarding in vitro assays
• Represented a next-generation sequencing company in a patent infringement action against a competitor; successfully obtained a preliminary injunction and a finding of infringement of multiple valid patents at trial
• Represented a health and nutrition products company in a multi-patent infringement action involving omega-3 oils
• Represented a construction materials manufacturer in an action seeking to revoke a competitor’s patent relating to ceramic abrasive particles; the patent in suit was found invalid
• Represented a tobacco company in proceedings concerning a competitor’s electrical engineering patent in the field to heat-not-burn tobacco; the patent was found invalid and in any event not infringed
• Represented a mobile network infrastructure company in patent proceedings concerning antenna technology
• Represented an implementor in a FRAND dispute, including successfully defending against a preliminary injunction; the proceedings were settled before any substantive trial
• Represented a multinational consumer devices company in relation to an allegation of design right infringement in the field of optical devices; the design rights were found not to have been infringed
• Represented a biotech company in patent revocation proceedings against a competitor; proceedings were settled shortly before trial
• Represented a biopesticides company in a case involving allegations of breach of contract and misuse of confidential information; the proceedings were settled shortly before trial
• Represented a biotech company in a multi-patent action in relation to a blockbuster antibody therapy; succeeded in obtaining Arrow relief
• Represented a major consumer electronics company in patent proceedings relating to mobile telephones; defendant’s patent found to be invalid

*Matters may have been conducted at a previous firm.